US Stock MarketDetailed Quotes

YMAB Y-mAbs Therapeutics

Watchlist

11.920
+0.040+0.34%

Close Nov 29 13:00 ET

11.920
0.0000.00%

Post 13:02 ET

533.89MMarket Cap-22074P/E (TTM)

Y-mAbs Therapeutics Stock Forum

Moomoo AI

Mar 24 10:01

Recent insider selling at Y-mAbs Therapeutics may indicate insiders believe shares are overpriced. The absence of insider purchases in the past year and low insider ownership warrant caution.

Selling US$1.9m Of Stock Was Lucrative Decision For Y-mAbs Therapeutics Insiders

Moomoo AI

Mar 3 08:57

The company's cash runway and revenue growth are positive. Its cash burn relative to market capitalisation is low, indicating potential for more cash raising with minimal dilution or borrowing. The company's cash burn is not a concern, suggesting it is well-positioned for continued growth funding.